Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

about

Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.

P2860

Q34158064-44990D3D-3B41-43AD-8D49-F45FA9C26169

P2860

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

Item

http://www.wikidata.org/entity/Q35925696

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@ast

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@en

type

Item

label

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@ast

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@en

prefLabel

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@ast

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@en

P1476

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

@en

P2093

Majaz Moonis

http://www.w3.org/2001/XMLSchema#string

Marc Fisher

http://www.w3.org/2001/XMLSchema#string

Vasamtha Padma

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease.

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association.

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.

The insula and cerebrogenic sudden death.

P304

867-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2.6.867

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15500432

http://www.w3.org/2001/XMLSchema#string

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

about

P2860

P2860

Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698